weight loss glp 1 agonists GLP-1 Drugs Market Report, 2025-2030 The New Weight Management Meds

The widespread distribution and function of multiple GLP-1 receptor populations in the central and autonomic nervous system provide the anatomical foundation for the appetite-suppressing effects observed with GLP-1 agonist therapy

They mimic the action of endogenous glucagon-like peptide 1, a hormone involved in glucose regulation and appetite control

and semaglutide (brand name Wegovy) followed in 2021

While GLP-1 receptor agonists have revolutionized the way we approach weight loss and diabetes management, their impact goes far beyond a number on the scale

Demand for weight loss treatments has surged, driven by increased awareness, social visibility, and the perceived effectiveness of GLP-1 drugs